Andrew Callos (EVP, Chief Commercial Officer) sold ~$113K of Cytokinetics
Automatic saleLoading…
Traded Dec 1, 2025 · Filed Dec 2, 2025
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
option exercise
Code M — exercise or conversion of a derivative security
None found in footnotes
Only flagged when a footnote says so; never inferred
Andrew Callos (EVP, Chief Commercial Officer) sold ~$113K of Cytokinetics
Automatic saleTraded Dec 22, 2025 · filed 7 days later
Compensation award — excluded from discretionary-purchase analysis.
Traded Dec 22, 2025 · filed 7 days later
Compensation award — excluded from discretionary-purchase analysis.